Influenza Vaccination After Acute Coronary Syndrome

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Acute Coronary Syndromes (ACS)

In brief

The goal of this clinical trial is to learn if influenza vaccination can prevent adverse cardiac events in Chinese acute coronary syndrome patients. The main questions it aims to answer are: * Whether influenza vaccination can decrease events of cardiovascular death, MI, or stroke? * Whether influenza vaccination can decrease events of all cause death, unplanned revascularization, unplanned hospitalization for heart failure or for arrhythmia, stent thrombosis? If there is a comparison group: Researchers will compare influenza vaccination and placebo to see if adverse cardiac events decrease. Participants will receive an influenza vaccination or placebo after enrollment and phone calls for follow-up at 1 month, 3 months, 6 months and 1 year after discharge.

Key facts

Study ID

NCT07259252

Run by

Tongji Hospital

People needed

6620

Starts

2025-12-03

Expected to finish

2029-03-30

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ACS patient aged from 18 to 80 years.
• Volunteer for the study and written informed consent.

You may not qualify if…

• Participate in any drug clinical trials within 3 months.
• Patients with life-threatening complications, or the researchers determined that the survival time of patients with no more than 1 years.
• Serious neurological disease (Alzheimer's disease, Parkinson syndrome, progressive lower limbs or deaf patients).
• Previous history of cancer or tumor, or pathological examination confirmed precancerous lesions (such as breast ductal carcinoma in situ, or atypical hyperplasia of the cervix).
• Patients refused to comply with the requirements of this study to complete the research work.
• Patients Received influenza vaccination within 1 year.
• Patients with contraindications for influenza vaccination.

Where it is running

• Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.